S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.29 (-5.45%)
BABA   186.80 (-0.19%)
GE   11.33 (-1.65%)
F   9.08 (+0.44%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.29 (-5.45%)
BABA   186.80 (-0.19%)
GE   11.33 (-1.65%)
F   9.08 (+0.44%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
Log in

Midatech Pharma Stock Price, Forecast & Analysis (NASDAQ:MTP)

$0.83
+0.01 (+1.22 %)
(As of 11/11/2019 04:00 PM ET)
Today's Range
$0.83
Now: $0.83
$0.84
50-Day Range
$0.83
MA: $1.22
$1.46
52-Week Range
$0.80
Now: $0.83
$10.90
Volume1,300 shs
Average Volume432,365 shs
Market Capitalization$2.54 million
P/E RatioN/A
Dividend YieldN/A
Beta2.75
Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTP
CUSIPN/A
Phone44-12-3588-8300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.59 million
Book Value$7.38 per share

Profitability

Miscellaneous

Employees73
Market Cap$2.54 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MTP News and Ratings via Email

Sign-up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter.


Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."

Has Midatech Pharma been receiving favorable news coverage?

Media coverage about MTP stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Midatech Pharma earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Midatech Pharma.

Who are some of Midatech Pharma's key competitors?

What other stocks do shareholders of Midatech Pharma own?

Who are Midatech Pharma's key executives?

Midatech Pharma's management team includes the folowing people:
  • Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 50)
  • Dr. Craig Richard Cook, CEO, COO & Director (Age 52)
  • Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.
  • Dr. Tim Sparey Ph.D., Chief Bus. Officer
  • Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing

How do I buy shares of Midatech Pharma?

Shares of MTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Midatech Pharma's stock price today?

One share of MTP stock can currently be purchased for approximately $0.83.

How big of a company is Midatech Pharma?

Midatech Pharma has a market capitalization of $2.54 million and generates $2.59 million in revenue each year. The company earns $-20,060,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis. Midatech Pharma employs 73 workers across the globe.View Additional Information About Midatech Pharma.

What is Midatech Pharma's official website?

The official website for Midatech Pharma is http://www.midatechpharma.com/.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA. The company can be reached via phone at 44-12-3588-8300 or via email at [email protected]


MarketBeat Community Rating for Midatech Pharma (NASDAQ MTP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  81 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote "Outperform" if you believe MTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/11/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel